NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
暂无分享,去创建一个
P. Gallo | F. Rinaldi | P. Perini | S. Zywicki | M. Anglani | M. Puthenparampil | L. Federle | E. Stropparo | C. Cazzola